News | July 29, 2025
Astec LifeSciences Q1 FY26 revenue up 30.3%
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Solara Active Pharma Sciences has reported total income of Rs. 320.13 crores during the period ended June 30, 2025
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Subscribe To Our Newsletter & Stay Updated
